<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="11" ids="26333">Prostaglandin</z:chebi> E therapy in infants causes <z:e sem="disease" ids="C0948707" disease_type="Disease or Syndrome" abbrv="">periosteal elevation</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Although the changes usually take 30-40 days to become visible, we have seen them as early as nine days </plain></SENT>
<SENT sid="2" pm="."><plain>In 15 infants who had <z:chebi fb="11" ids="26333">prostaglandin</z:chebi> E therapy for over six days, three developed <z:e sem="disease" ids="C0948707" disease_type="Disease or Syndrome" abbrv="">periosteal elevation</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Three other cases are described in greater detail, with long-term follow-up in two in which the bone remodeled to <z:mpath ids='MPATH_458'>normal</z:mpath> </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="29" ids="49631">Gallium</z:chebi> scan in one showed increased uptake in areas involved </plain></SENT>
<SENT sid="5" pm="."><plain>The periosteal cloaking may mimic <z:e sem="disease" ids="C0020497" disease_type="Disease or Syndrome" abbrv="">Caffey disease</z:e> but the pattern of involvement is different, since the mandible, which is commonly affected in <z:e sem="disease" ids="C0020497" disease_type="Disease or Syndrome" abbrv="">Caffey disease</z:e>, is rarely involved in <z:chebi fb="11" ids="26333">prostaglandin</z:chebi> E therapy </plain></SENT>
</text></document>